Arrowhead Pharmaceuticals
ARWR
#2176
Rank
โ‚ฌ7.29 B
Marketcap
52,77ย โ‚ฌ
Share price
-4.98%
Change (1 day)
136.15%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚ฌ0.73 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚ฌ0.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Arrowhead Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30โ‚ฌ0.85 B88.52%
2023-09-30โ‚ฌ0.45 B61.6%
2022-09-30โ‚ฌ0.27 B7.41%
2021-09-30โ‚ฌ0.26 B402.71%
2020-09-30โ‚ฌ51.78 M-46.65%
2019-09-30โ‚ฌ97.07 M588.25%
2018-09-30โ‚ฌ14.1 M-28.48%
2017-09-30โ‚ฌ19.72 M-33.33%
2016-09-30โ‚ฌ29.57 M45.92%
2015-09-30โ‚ฌ20.27 M52.09%
2014-09-30โ‚ฌ13.32 M55.47%
2013-09-30โ‚ฌ8.57 M42.26%
2012-09-30โ‚ฌ6.02 M146.02%
2011-09-30โ‚ฌ2.44 M-21.97%
2010-09-30โ‚ฌ3.13 M60.21%
2009-09-30โ‚ฌ1.95 M-44.55%
2008-09-30โ‚ฌ3.53 M48.11%
2007-09-30โ‚ฌ2.38 M3.43%
2006-09-30โ‚ฌ2.3 M170.68%
2005-09-30โ‚ฌ0.85 M53.39%
2004-09-30โ‚ฌ0.55 M571.6%
2003-09-30โ‚ฌ0.08 M-94.97%
2002-09-30โ‚ฌ1.64 M10.82%
2001-09-30โ‚ฌ1.48 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alnylam Pharmaceuticals
ALNY
โ‚ฌ3.96 B 436.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.45 B-38.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
โ‚ฌ66.22 M-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 13,089.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
โ‚ฌ2.40 B 225.86%๐Ÿ‡บ๐Ÿ‡ธ USA